Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients.

Scandinavian journal of infectious diseases - 1 Jan 2004

Lerbaek Anne, Kristiansen Thomas B, Katzenstein Terese L, Mathiesen Lars, Gerstoft Jan, Nielsen Claus, Larsen Klaus, Nielsen Jens O, Obel Niels, Laursen Alex L, Nielsen Susanne D

Abstract excerpt

The aim of the present study was to explore the treatment effect of tenofovir as implemented in clinical practice. Data are presented on 34 patients. 11 patients had tenofovir added to a stable anti-retroviral treatment (ART) and 23 patients had drugs other than tenofovir. CD4 counts, HIV-RNA levels and genotypic resistance were determined at baseline and after 3 and 6 months. After initiation of tenofovir...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Therapy, Combination

Share to Organophosphonates

Share to Organophosphorus Compounds

Share to Reverse Transcriptase Inhibitors

Share to Tenofovir

Source

Identifiers

PMID: 15198185
DOI: 10.1080/00365540410019633

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patients.PMID 15198185Read ↗

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.Semantic proximity Read ↗

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.Semantic proximity Read ↗

Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.Semantic proximity Read ↗

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.Semantic proximity Read ↗

Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.Semantic proximity Read ↗

The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.Semantic proximity Read ↗

Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples.Semantic proximity Read ↗

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.Semantic proximity Read ↗

Early virological failure after tenofovir + didanosine + efavirenz combination in HIV-positive patients upon starting antiretroviral therapy.Semantic proximity Read ↗

Early virological failure with a combination of tenofovir, didanosine and efavirenz.Semantic proximity Read ↗

Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations.Semantic proximity Read ↗

High rate of virological failure in maintenance antiretroviral therapy with didanosine and tenofovir.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.